Director of Gladstone Institute of Cardiovascular Disease elected to Institute of Medicine

October 20, 2014

Deepak Srivastava, MD, the Director of the Gladstone Institute of Cardiovascular Disease and Director of the Roddenberry Center for Stem Cell Biology and Medicine, has been elected to the National Academy of Sciences' Institute of Medicine (IOM).

The IOM serves as both an honorific society and an advisory organization, providing guidance to the government and private sector on matters of healthcare and medicine. Election to the Institute is considered to be one of the highest honors in medical science, identifying individuals who have made major contributions to the field.

"I am honored to be named to this prestigious institution and pleased that this election recognizes the dedication and creativity of the team of scientists I have had the privilege to work with over the last two decades," said Dr. Srivastava, who is also a Professor of Pediatrics and Biochemistry & Biophysics at the University of California, San Francisco.

Gladstone President R. Sanders "Sandy" Williams, MD, congratulated Dr. Srivastava on the election, saying, "Deepak's accomplishments in cardiovascular research are exceptional. This acknowledgment of his professional achievements and commitment to service is very much deserved." Dr. Srivastava joins Dr. Williams, President Emeritus Robert Mahley, MD, PhD, and Director of the Gladstone Institute of Virology and Immunology Warner Greene, MD, PhD, as members of the IOM.

With a background in pediatric cardiology, Dr. Srivastava has led the charge on discovering which genes are essential for the formation of the heart from stem cells in the womb, and which ones are to blame when this process goes wrong in children with cardiac defects. He was also the first to describe the role of tiny molecules in the heart--called microRNAs--which carefully titrate levels of gene activity to control the fate of cells. Dr. Srivastava showed that when cells in the heart get confused about their fate it can result in disease, like when cells in the valve start behaving like bone cells and deposit calcium--a leading cause of heart disease.

He has most recently used the knowledge of how a heart is built in an embryo to create beating heart muscle cells from connective tissue in adult animals, effectively regenerating healthy muscle cells from scar tissue after a heart attack. This research could one day help restore heart function in the over 23 million people who suffer from heart failure worldwide.

Before joining Gladstone in 2005, Dr. Srivastava was a professor in the Departments of Pediatrics and Molecular Biology at the University of Texas Southwestern Medical Center in Dallas.

Dr. Srivastava's previous honors and awards include election to the American Society for Clinical Investigation, the American Academy of Arts and Sciences, and the American Association for the Advancement of Science.
-end-


Gladstone Institutes

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.